Filing Details
- Accession Number:
- 0001240679-19-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-10 18:34:22
- Reporting Period:
- 2019-12-05
- Accepted Time:
- 2019-12-10 18:34:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
914156 | Ufp Technologies Inc | UFPT | Surgical & Medical Instruments & Apparatus (3841) | 042314970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1722604 | P. Christopher Litterio | C/O Ufp Technologies, Inc. 100 Hale Street Newburyport MA 01950 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2019-12-05 | 5,000 | $28.70 | 11,289 | No | 4 | M | Direct | |
Common Stock, $.01 Par Value | Disposition | 2019-12-06 | 4,900 | $45.50 | 1,389 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2019-12-06 | 100 | $46.34 | 1,289 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Stock Option (Right to Buy) | Acquisiton | 2019-12-05 | 0 | $0.00 | 0 | $28.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-12-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.02 to $45.78, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The option became exercisable with respect to 25% of the shares on 12/15/17 with respect to an additional 25% of the shares on each of the three anniversary dates thereafter.